Kenvue Inc. (KVUE)
NYSE
Real-time Data
01:30 PM
Day's Range
17.5252 wk Range
14.02Overview - KVUE - Kenvue Inc.
Key Statistics
Valuation
Enterprise Value
41.69B
P/E (Trailing)
‪20.94‬
P/E (Forward)
‪14.35‬
PEG Ratio
‪2.30‬
Price / Sales (TTM)
‪2.21‬
Price / Book
‪3.23‬
EV / EBITDA
‪11.97‬
Profitability
Gross Margin
‪58.17%‬
Profit Margin
‪10.76%‬
Operating Margin
‪19.41%‬
Return on Assets
‪6.99%‬
Return on Equity
‪15.58%‬
Ownership
Shares Outstanding
1.92B
Float
1.91B
Short % of Shares Outstanding
‪3.48%‬
Held by Insiders
‪0.07%‬
Held by Institutions
‪95.92%‬
Price stats
Beta
‪0.42‬
50-Day Avg
‪18.78‬
200-Day Avg
‪18.03‬
Dividends
Payout Ratio
‪97.65%‬
Frequency
Quarterly
Analyst Consensus
14 analysts
Average price target
‪$ 19.50‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - KVUE - Kenvue Inc.
Peers - KVUE - Kenvue Inc.
Peer Comparison
Compared with companies in Household & Personal Products listed on NYSE.
Profile Summary - KVUE - Kenvue Inc.
About
Kenvue Inc. is a consumer health company focused on everyday care products across self care, skin health and beauty, and essential health. Kenvue’s portfolio includes well-known brands such as Tylenol, Neutrogena, Aveeno, Listerine, Johnson’s, BAND-AID Brand, Zyrtec, and Nicorette, serving needs in pain relief, cough…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
